Mucormycosis and COVID-19: An epidemic within a pandemic in India.

L, Selarka; S, Sharma; D, Saini; S, Sharma; A, Batra; VT, Waghmare; P, Dileep; S, Patel; M, Shah; T, Parikh; P, Darji; A, Patel; G, Goswami; A, Shah; S, Shah; H, Lathiya; M, Shah; P, Sharma; S, Chopra; A, Gupta; N, Jain; E, Khan; VK, Sharma; AK, Sharma; ACY, Chan; JJY, Ong

doi:10.1111/myc.13353

Public

Mucormycosis and COVID-19: An epidemic within a pandemic in India.

Shared by NobleBlocks on Jul 24, 2021 • 12:00 AM UTC

Authors:

Selarka L

Sharma S

Saini D

Abstract

<h4>Importance</h4>Coronavirus disease (COVID-19) causes an immunosuppressed state and increases risk of secondary infections like mucormycosis. We evaluated clinical features, predisposing factors, diagnosis and outcomes for mucormycosis among patients with COVID-19 infection.<h4>Methods</h4>This p...

Subject

Diabetes mellitus

Mucormycosis

Systemic Corticosteroids

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!